Table 2.
Baseline demographics comparing participants with and without new T2 lesions.
| M/F | Age (years) | Baseline EDSS | EDSS change | Disease duration (years) | Number of MRI visits | Number of relapses | ARR | Participants with relapses | |
|---|---|---|---|---|---|---|---|---|---|
| Participants with new lesions | 5/8 | 47.62 (±12.5) | 2.5 (±1.93) | 0.5 (±0.98) | 15.69 (±8.14) | 3.31 (±0.63) | 0.46 (±0.66) | 0.3 (±0.52) | 5 |
| Participants without new lesions | 1/11 | 54.33 (±8.09) | 3.25 (±1.73) | 0.0 (±0.39) | 21.83 (±9.81) | 3.33 (±0.78) | 0.08 (±0.29) | 0.06 (±0.19) | 1 |
| p-value | 0.06 | 0.31 | 0.07 | 0.05 | 0.46 | 0.04 | 0.03 |
EDSS: Expanded Disability Status Scale; MRI: magnetic resonance imaging; ARR: annualized relapse rate.
Values reported as mean value (±standard deviation); EDSS and EDSS change are reported as median (±standard deviation).
p-values determined by unpaired one-tailed t-tests.